Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension (Q36730246)
Jump to navigation
Jump to search
scientific article published on 7 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension |
scientific article published on 7 February 2013 |
Statements
1 reference
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension (English)
1 reference
Chantal Mathieu
1 reference
Edward Franek
1 reference
Priscilla Hollander
1 reference
Bresta Miranda-Palma
1 reference
John Cooper
1 reference
David Russell-Jones
1 reference
Jens Larsen
1 reference
Søren Can Tamer
1 reference
Stephen C Bain
1 reference
NN1250-3770 (BEGIN: Flex T1) Trial Investigators
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference